Literature DB >> 35382129

Orofacial consequences of systemic sclerosis: A systematic review.

Rawen Smirani1,2, Nicolas Poursac3, Adrien Naveau1,2,4, Thierry Schaeverbeke3, Raphaël Devillard1,2,4, Marie-Elise Truchetet3,5.   

Abstract

Orofacial involvement is common and often understated in the treatment clinical guidelines of systemic sclerosis. It impairs daily life by having repercussions on comfort, nutrition, aesthetics and self-confidence. This review aimed at describing exhaustively the different orofacial consequences of systemic sclerosis. A systematic search was conducted using four databases (PubMed, Cochrane Library, Dentistry & Oral Sciences Source and SCOPUS) up to December 2016 according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses. Grey literature and hand search were also included. To be eligible for the inclusion, studies needed to meet the following criteria: randomised controlled trials, cross-sectional studies, case-control studies, pilot studies or cohort studies and full text available in English or French, with abstract. The studies had to concern at least 30 patients suffering from systemic sclerosis and having clinical and radiological oropharyngeal examination. The diagnosis of systemic sclerosis had to be determined according to precise recommendations; the retrieved oropharyngeal manifestations had to affect hard or soft tissues of the mouth and/or pharynx and needed to be evaluated with clinical measures. Study selection, risk bias assessment (Newcastle-Ottawa scale) and data extraction were performed by two independent reviewers. The retrieved features were microstomia and xerostomia associated with real hyposialia, temporomandibular joint symptoms, high caries experience, periodontal diseases as well as an increased risk of oral cavity and pharynx cancer. Early diagnosis enabling early management, prevention and oral hygiene is the key to avoid complicated and invasive procedures. Studies with higher level of evidence remain necessary to create standardised protocols.
© The Author(s) 2018.

Entities:  

Keywords:  Mouth diseases; Oral medicine; Oral pathology; Scleroderma systemic

Year:  2018        PMID: 35382129      PMCID: PMC8892883          DOI: 10.1177/2397198317746966

Source DB:  PubMed          Journal:  J Scleroderma Relat Disord        ISSN: 2397-1983


  37 in total

Review 1.  Recommendations for the care of oral involvement in patients with systemic sclerosis.

Authors:  Alp Alantar; Jean Cabane; Eric Hachulla; Guy Princ; Danielle Ginisty; Michel Hassin; Marc Sorel; Louis Maman; Aurélie Pilat; Luc Mouthon
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-08       Impact factor: 4.794

2.  Gastrointestinal Manifestations of Systemic Sclerosis.

Authors:  Andrew B Shreiner; Charles Murray; Christopher Denton; Dinesh Khanna
Journal:  J Scleroderma Relat Disord       Date:  2016-10-18

3.  Cancer risk among patients with systemic sclerosis: a nationwide population study in Taiwan.

Authors:  C-F Kuo; S-F Luo; K-H Yu; I-J Chou; W-Y Tseng; H-C Chang; Y-F Fang; M-J Chiou; L-C See
Journal:  Scand J Rheumatol       Date:  2011-12-11       Impact factor: 3.641

Review 4.  Effectiveness of Nonpharmacologic Interventions in Systemic Sclerosis: A Systematic Review.

Authors:  Linda M Willems; Johanna E Vriezekolk; Anne A Schouffoer; Janet L Poole; Tanja A Stamm; Carina Boström; Linda Kwakkenbos; Theodora P M Vliet Vlieland; Cornelia H M van den Ende
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-10       Impact factor: 4.794

5.  Mandibular function is severely impaired in systemic sclerosis patients.

Authors:  Edna Livia A Ferreira; Romy B Christmann; Eduardo F Borba; Claudia T L Borges; Jose T T Siqueira; Eloisa Bonfa
Journal:  J Orofac Pain       Date:  2010

6.  Increased incidence of Sjogren's syndrome in systemic sclerosis: A nationwide population study.

Authors:  Chia-Chun Tseng; Jeng-Hsien Yen; Wen-Chan Tsai; Tsan-Teng Ou; Cheng-Chin Wu; Wan-Yu Sung; Ming-Chia Hsieh; Shun-Jen Chang
Journal:  Autoimmunity       Date:  2015-05-18       Impact factor: 2.815

7.  The Canadian systemic sclerosis oral health study: orofacial manifestations and oral health-related quality of life in systemic sclerosis compared with the general population.

Authors:  Murray Baron; Marie Hudson; Solène Tatibouet; Russell Steele; Ernest Lo; Sabrina Gravel; Geneviève Gyger; Tarek El Sayegh; Janet Pope; Audrey Fontaine; Ariel Masseto; Debora Matthews; Evelyn Sutton; Norman Thie; Niall Jones; Maria Copete; Dean Kolbinson; Janet Markland; Getulio Nogueira-Filho; David Robinson; Mervyn Gornitsky
Journal:  Rheumatology (Oxford)       Date:  2014-01-24       Impact factor: 7.580

8.  The frequency of sicca symptoms and Sjögren's syndrome in patients with systemic sclerosis.

Authors:  Senol Kobak; Fahrettin Oksel; Kenan Aksu; Yasemin Kabasakal
Journal:  Int J Rheum Dis       Date:  2012-08-31       Impact factor: 2.454

9.  Relationship between disease characteristics and orofacial manifestations in systemic sclerosis: Canadian Systemic Sclerosis Oral Health Study III.

Authors:  Murray Baron; Marie Hudson; Solène Tatibouet; Russell Steele; Ernest Lo; Sabrina Gravel; Geneviève Gyger; Tarek El Sayegh; Janet Pope; Audrey Fontaine; Ariel Masetto; Debora Matthews; Evelyn Sutton; Norman Thie; Niall Jones; Maria Copete; Dean Kolbinson; Janet Markland; Getulio Nogueira; David Robinson; Marvin Fritzler; Mervyn Gornitsky
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-05       Impact factor: 4.794

10.  Orofacial Manifestations and Temporomandibular Disorders of Systemic Scleroderma: An Observational Study.

Authors:  Vito Crincoli; Laura Fatone; Margherita Fanelli; Rossana Patricia Rotolo; Angela Chialà; Gianfranco Favia; Giovanni Lapadula
Journal:  Int J Mol Sci       Date:  2016-07-22       Impact factor: 5.923

View more
  1 in total

Review 1.  Autoimmune disease and oral squamous cell carcinoma: A systematic review.

Authors:  Anjali Pillai; Dauren Adilbay; Konstantina Matsoukas; Ian Ganly; Snehal G Patel
Journal:  J Oral Pathol Med       Date:  2021-07-12       Impact factor: 3.539

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.